Symmex unveils solution to support NAFDAC, drug production

In Nigeria, innovation is often born out of necessity, and the development of the Huraflow-MES platform by Symmex Smart Workings Limited is a prime example. The company's initiative to present this locally designed Manufacturing Execution System to the National Agency for Food and Drug Administration and Control (NAFDAC) highlights a critical need for technological advancement within our nation's regulatory and industrial sectors.

“

It remains difficult for people to genuinely do things, even though they know that it is painful using manual processes. Adopting the digital system is still not a walk in the park.

Symmex's Huraflow-MES is not just another software; it's a strategic tool designed to tackle the persistent challenges of manual processes and limited digitization that plague our manufacturing landscape, particularly in pharmaceuticals. The platform's ability to integrate core manufacturing elements—materials, machines, manpower, and methods—into a unified digital interface offers a glimpse into a more efficient and compliant future.

“

The sector they are supposed to regulate grows faster than they can grow as an institution, in terms of manpower and resources.

What makes this development particularly significant from a Nigerian perspective is its focus on empowering our regulatory bodies. As Symmex CEO Olumide Awoyemi points out, regulatory agencies like NAFDAC often struggle to keep pace with the rapid expansion of the industries they oversee due to limitations in manpower and resources. Huraflow-MES directly addresses this by introducing a remote inspection model. This not only enhances efficiency but also allows regulators to focus on high-risk areas, a pragmatic approach tailored to our local context.

“

So, what this system does is, based on agreement, get them access to electronic records… They can now go on-site to places where there are actual issues, not wait until they go on-site to see problems.

Furthermore, the platform's emphasis on patient safety through tamper-evident audit trails and faster product recalls is crucial for building trust in our pharmaceutical products, both domestically and internationally. Symmex's ambition to build a comprehensive, end-to-end digital infrastructure for the life sciences sector positions them as a key player in Nigeria's technological advancement, demonstrating local capacity to solve complex, industry-wide problems.

“

With a digital and electronic system, you can naturally start an investigation and get to the pain point in three, four hours… you can pull out granular information on that batch.